Mayne Pharma Group Ltd
ASX:MYX
Mayne Pharma Group Ltd
Selling, General & Administrative
Mayne Pharma Group Ltd
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mayne Pharma Group Ltd
ASX:MYX
|
Selling, General & Administrative
-AU$190m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Selling, General & Administrative
-AU$14.9m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Selling, General & Administrative
-AU$5.9m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-10%
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Selling, General & Administrative
-AU$10m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-34%
|
|
Probiotec Ltd
ASX:PBP
|
Selling, General & Administrative
-AU$33.7m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-4%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Selling, General & Administrative
-AU$4.7m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mayne Pharma Group Ltd's Selling, General & Administrative?
Selling, General & Administrative
-190m
AUD
Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Selling, General & Administrative amounts to -190m AUD.
What is Mayne Pharma Group Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-7%
Over the last year, the Selling, General & Administrative growth was -42%. The average annual Selling, General & Administrative growth rates for Mayne Pharma Group Ltd have been -13% over the past three years , -7% over the past five years .